These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12901099)

  • 21. [Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
    Dai Y; Liu XJ; Zhen YS
    Yao Xue Xue Bao; 2006 Jan; 41(1):41-6. PubMed ID: 16683526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characterization of cell death induced by anticancer antibiotic lidamycin in human hepatoma BEL-7402 cells].
    He QY; Liang YY; Wang DS; Li DD
    Yao Xue Xue Bao; 2001 Mar; 36(3):174-8. PubMed ID: 12580082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activities of dFv-LDP-AE: An enediyne-energized fusion protein targeting tumor-associated antigen gelatinases.
    Zhong GS; Wu MN; Guo XF; Zhang SH; Miao QF; Zhen YS
    Oncol Rep; 2012 Oct; 28(4):1193-9. PubMed ID: 22797730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.
    Knoll K; Wrasidlo W; Scherberich JE; Gaedicke G; Fischer P
    Cancer Res; 2000 Nov; 60(21):6089-94. PubMed ID: 11085532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of lidamycin on mitochondria initiated apoptotic pathway in human cancer cells].
    Qiu Q; Wang Z; Jiang JM; Li DD
    Yao Xue Xue Bao; 2007 Feb; 42(2):132-8. PubMed ID: 17518039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel antibody-drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity.
    Jiang L; Yang M; Zhang X; Bao S; Ma L; Fan D; Zhou Y; Xiong D; Zhen Y
    J Drug Target; 2016; 24(1):47-57. PubMed ID: 26204323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Potentiation and mechanism of cisplatin-induced apoptosis by lidamycin in human hepatoma BEL-7402 cells].
    Liu HZ; Li DD; Zhen YS; Shao RG
    Yao Xue Xue Bao; 2003 Apr; 38(4):250-4. PubMed ID: 12889121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lidamycin induces marked G2 cell cycle arrest in human colon carcinoma HT-29 cells through activation of p38 MAPK pathway.
    Liu X; Bian C; Ren K; Jin H; Li B; Shao RG
    Oncol Rep; 2007 Mar; 17(3):597-603. PubMed ID: 17273739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of the conjugate composed of a human monoclonal antibody and pingyangmycin on mammary cancer].
    Wang WG; Wang SH; Xue YC; Zhen YS
    Yao Xue Xue Bao; 1995; 30(8):583-7. PubMed ID: 8571778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin.
    Miao Q; Shang B; Ouyang Z; Liu X; Zhen Y
    Sci China C Life Sci; 2007 Aug; 50(4):447-56. PubMed ID: 17653664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).
    Blumenthal RD; Hansen HJ; Goldenberg DM
    Cancer Res; 2005 Oct; 65(19):8809-17. PubMed ID: 16204051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of monoclonal antibody-pinyangmycin conjugate in experimental regional targeting therapy of tumor].
    Wang WG; Xu LN; Zhang SH; Xue YC; Zhen YS
    Yao Xue Xue Bao; 1997 Sep; 32(9):669-74. PubMed ID: 11596291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-GAD antibody targeted non-viral gene delivery to islet beta cells.
    Jeong JH; Lee M; Kim WJ; Yockman JW; Park TG; Kim YH; Kim SW
    J Control Release; 2005 Oct; 107(3):562-70. PubMed ID: 16139384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.
    Behr TM; Sharkey RM; Juweid ME; Blumenthal RD; Dunn RM; Griffiths GL; Bair HJ; Wolf FG; Becker WS; Goldenberg DM
    Cancer Res; 1995 Sep; 55(17):3825-34. PubMed ID: 7641200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
    Pastorino F; Brignole C; Marimpietri D; Sapra P; Moase EH; Allen TM; Ponzoni M
    Cancer Res; 2003 Jan; 63(1):86-92. PubMed ID: 12517782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
    Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
    Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
    Brusa P; Dosio F; Coppo S; Pacchioni D; Arpicco S; Crosasso P; Cattel L
    Farmaco; 1997 Feb; 52(2):71-81. PubMed ID: 9181686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
    Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient inhibition of B-cell lymphoma xenografts with a novel recombinant fusion protein: anti-CD20Fab-LDM.
    Xin C; Ye S; Ming Y; Shenghua Z; Qingfang M; Hongxing G; Xu S; Yuanfu X; Yuan Z; Dongmei F; Juanni L; Yingdai G; Lianfang J; Rongguang S; Zhenping Z; Jianxiang W; Tao C; Chunzheng Y; Dongsheng X; Yongsu Z
    Gene Ther; 2010 Oct; 17(10):1234-43. PubMed ID: 20463754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.